These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35898652)

  • 21. Impaired cliff avoidance reaction in dopamine transporter knockout mice.
    Yamashita M; Sakakibara Y; Hall FS; Numachi Y; Yoshida S; Kobayashi H; Uchiumi O; Uhl GR; Kasahara Y; Sora I
    Psychopharmacology (Berl); 2013 Jun; 227(4):741-9. PubMed ID: 23397052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice.
    Spielewoy C; Roubert C; Hamon M; Nosten-Bertrand M; Betancur C; Giros B
    Behav Pharmacol; 2000 Jun; 11(3-4):279-90. PubMed ID: 11103882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of Spatial Memory Deficit and Hyperactivity in Dopamine Transporter Knockout Rats
    Kurzina N; Belskaya A; Gromova A; Ignashchenkova A; Gainetdinov RR; Volnova A
    Front Psychiatry; 2022; 13():851296. PubMed ID: 35401264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter.
    Ragu Varman D; Subler MA; Windle JJ; Jayanthi LD; Ramamoorthy S
    Behav Brain Res; 2021 Jun; 408():113267. PubMed ID: 33794225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice.
    Weiss S; Tzavara ET; Davis RJ; Nomikos GG; Michael McIntosh J; Giros B; Martres MP
    Neuropharmacology; 2007 Jun; 52(7):1496-508. PubMed ID: 17433376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
    Morice E; Denis C; Giros B; Nosten-Bertrand M
    Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new "sudden fright paradigm" to explore the role of (epi)genetic modulations of the DAT gene in fear-induced avoidance behavior.
    Zelli S; Brancato A; Mattioli F; Pepe M; Alleva E; Carbone C; Cannizzaro C; Adriani W
    Genes Brain Behav; 2021 Apr; 20(4):e12709. PubMed ID: 33070435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
    Uchiumi O; Kasahara Y; Fukui A; Hall FS; Uhl GR; Sora I
    Neuropharmacology; 2013 Jan; 64():348-56. PubMed ID: 22809709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased ethanol preference and consumption in dopamine transporter female knock-out mice.
    Savelieva KV; Caudle WM; Findlay GS; Caron MG; Miller GW
    Alcohol Clin Exp Res; 2002 Jun; 26(6):758-64. PubMed ID: 12068242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze.
    Kurzina NP; Aristova IY; Volnova AB; Gainetdinov RR
    Behav Brain Res; 2020 Jul; 390():112642. PubMed ID: 32428629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice.
    Chen R; Furman CA; Zhang M; Kim MN; Gereau RW; Leitges M; Gnegy ME
    J Pharmacol Exp Ther; 2009 Mar; 328(3):912-20. PubMed ID: 19098163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor Transitions' Peculiarity of Heterozygous DAT Rats When Offspring of an Unconventional KOxWT Mating.
    Carbone C; Brancato A; Adinolfi A; Lo Russo SLM; Alleva E; Cannizzaro C; Adriani W
    Neuroscience; 2020 May; 433():108-120. PubMed ID: 32171819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward evidence-based severity assessment in rat models with repeated seizures: III. Electrical post-status epilepticus model.
    Seiffert I; van Dijk RM; Koska I; Di Liberto V; Möller C; Palme R; Hellweg R; Potschka H
    Epilepsia; 2019 Aug; 60(8):1539-1551. PubMed ID: 31247135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reward sensitivity deficits in a rat model of compulsive eating behavior.
    Moore CF; Leonard MZ; Micovic NM; Miczek KA; Sabino V; Cottone P
    Neuropsychopharmacology; 2020 Mar; 45(4):589-596. PubMed ID: 31622973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic modulation of the circadian activity and sociability: Dissecting parental inheritance versus maternal styles as determinants of epigenetic influence.
    Oggiano M; Buccheri C; Alleva E; Adriani W
    Behav Brain Res; 2022 Jan; 417():113623. PubMed ID: 34624423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system.
    Ralph-Williams RJ; Paulus MP; Zhuang X; Hen R; Geyer MA
    Biol Psychiatry; 2003 Feb; 53(4):352-9. PubMed ID: 12586455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons.
    Berlanga ML; Price DL; Phung BS; Giuly R; Terada M; Yamada N; Cyr M; Caron MG; Laakso A; Martone ME; Ellisman MH
    Brain Res; 2011 May; 1390():41-9. PubMed ID: 21439946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.
    Barr AM; Lehmann-Masten V; Paulus M; Gainetdinov RR; Caron MG; Geyer MA
    Neuropsychopharmacology; 2004 Feb; 29(2):221-8. PubMed ID: 14603268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease.
    Miller GW; Wang YM; Gainetdinov RR; Caron MG
    Methods Mol Med; 2001; 62():179-90. PubMed ID: 21318776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
    Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.